National Research Corporation logo

National Research Corporation (NR1A)

Market Closed
14 Oct, 07:57 PM
XSTU XSTU
€
18. 10
+0.3
+1.6854%
€
- Market Cap
33.66 P/E Ratio
0.64% Div Yield
0 Volume
0 Eps
€ 17.8
Previous Close
Add Transaction
Day Range
17.4 18.2
Year Range
9.55 20
Want to track NR1A and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

NR1A closed Wednesday higher at €18.1, an increase of 1.6854% from Tuesday's close, completing a monthly decrease of -0.5495% or -€0.1. Over the past 12 months, NR1A stock gained 15.2866%.
NR1A pays dividends to its shareholders, with the most recent payment made on Oct 09, 2026. The next estimated payment will be in In 2 months on Jan 09, 2027 for a total of €0.16.
The last earnings report, released on May 05, 2026, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 5 different exchanges and in various currencies, with the primary listing on NASDAQ (NGS) (USD).

NR1A Chart

NRC Down 8% Despite Q2 Earnings Rising Y/Y on TRCV Growth

NRC Down 8% Despite Q2 Earnings Rising Y/Y on TRCV Growth

NRC Health's Q2 earnings per share rise year over year on higher recurring contract value and strong Governance Institute bookings, partly offset by elevated operating expenses.

Zacks | 2 months ago
NRC Health (NRC) Q2 2026 Earnings Call Transcript

NRC Health (NRC) Q2 2026 Earnings Call Transcript

NRC Health (NRC) Q2 2026 Earnings Call Transcript

Seekingalpha | 2 months ago
National Research Q2 Earnings Call Highlights

National Research Q2 Earnings Call Highlights

National Research NASDAQ: NRC, operating as NRC Health, reported second-quarter results marked by 11% year-over-year growth in total recurring contract value, while management said investments in implementation, customer success and product development supported a large customer deployment and future growth initiatives.

Marketbeat | 2 months ago

National Research Corporation (NR1A) FAQ

What is the stock price today?

The current price is €18.10.

On which exchange is it traded?

National Research Corporation is listed on XSTU.

What is its stock symbol?

The ticker symbol is NR1A.

Does it pay dividends? What is the current yield?

Yes, It pays dividends and the current yield is 0.64%.

What is its market cap?

As of today, no market cap data is available.

Has National Research Corporation ever had a stock split?

No, there has never been a stock split.

National Research Corporation Profile

Health Care Equipment & Supplies Industry
Healthcare Sector
Trent Green CEO
XSTU Exchange
US6373722023 ISIN
US Country
357 Employees
25 Sep 2026 Last Dividend
- Last Split
10 Oct 1997 IPO Date

Overview

Founded in 1981 and based in Lincoln, Nebraska, National Research Corporation is a leader in delivering comprehensive analytics and insights designed to enhance both patient and employee experiences within the healthcare sector. The company's offerings span across critical areas such as patient experience, service recovery, care transitions, and employee engagement, among others. Its mission is to provide healthcare organizations with actionable information and analysis that support improvement initiatives, reputation management, and brand loyalty efforts. National Research Corporation's solutions cater to a wide array of needs, aligning with the goals of maximizing constituent satisfaction and organizational effectiveness in healthcare settings.

Products and Services

National Research Corporation's suite of products and services is meticulously crafted to address various facets of healthcare organization needs, with a focus on delivering actionable insights for improvement and strategic management. Key offerings include:

  • Analytics and Insights: These tools are designed to measure and enhance patient and employee experiences, offering a foundation for targeted interventions in service recovery and care transitions. By leveraging these insights, healthcare organizations can better understand and act on the complex dynamics affecting patient and employee satisfaction.
  • Marketing Solutions: Focused on elevating healthcare brands, these solutions track brand awareness, perception, and consistency. Competitor differentiators are assessed, and advanced segmentation tools are employed to discern community needs, preferences, and behaviors, enabling real-time competitive assessments.
  • Experience Solutions: This category includes tailored solutions aimed at improving patient experience and employee engagement, through health risk assessments, care transition tools, and other targeted improvement instruments. These services empower health organizations to deepen their understanding of and response to the experiences of their patients and staff.
  • Reputation Solutions: To bolster healthcare organizations' public image, these solutions facilitate the distribution of timely and relevant content that shapes consumer perceptions and informs decision-making. They are designed to ensure that the organization's narrative is positively reflected in the public domain.
  • Governance Solutions: Specifically designed for the boards of directors, executives, and physician leaders of not-for-profit hospitals and health systems, these services offer strategic oversight tools and resources. They support effective governance practices, ensuring that leadership is aligned with both mission and performance objectives.

Contact Information

Address: 1245 Q Street
Phone: 402 475 2525